Keytruda May Soon Be Approved for Lung Cancer Treatment in EU
News
Merck recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approving Keytruda (pembrolizumab) for locally advanced or metastatic non-small cell lung ... Read more